Abstract
We evaluated the prognostic value of BAALC expression in 86 patients with acute promyelocytic leukemia (APL).At 10 years, the overall survival (OS) was 66% in all patients and 75% in patients who achieved a complete remission (CR). Patients in the BAALClow group showed an OS of 87% as compared to 60% in the BAALChigh group (p=0.019). This difference was more pronounced in treatment responders (92% vs. 70%; p=0.035). In multivariate analyses low BAALC expression retained its prognostic relevance.In conclusion, BAALC expression analysis might be useful in further risk stratification in APL patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
